Share
Trueinvivo exhibited (and attended) the International Conference on Dosimetry and its Applications (ICDA-2) at the University of Surrey from 3rd to 8th July 2016. There was great interest in the micro silica beads and their potential use. The company also made very good international connections and is in the process of signing a Memorandum of Understanding (MOU) with another organisation.
Related Posts
George Sutherland appointed TRUEinvivo Ltd.'s first Chairman, bringing extensive experience in medical devices and corporate finance.
TRUEinvivo's 2018 achievements include prototype development, patent filings, fundraising, multiple awards, and market expansion, setting the stage for a busy 2019.
TrueInvivo's implant improves cancer treatment accuracy, accessible globally, supported by UKTI Sirius Programme.
Revolutionary DOSEmapper™ reader produces glow curve graph, offering rapid measurement compared to traditional TLD readers.
